Instituto de Investigación, Innovación y Tecnología Educativas (UNIR iTED)
Facultad
Duke Clinical Research Institute
Durham, Estados UnidosPublicacións en colaboración con investigadores/as de Duke Clinical Research Institute (7)
2012
-
Impact of IL28b gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1246-1249
-
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with All HCV genotypes
Journal of Infectious Diseases, Vol. 205, Núm. 3, pp. 376-383
2011
-
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
AIDS, Vol. 25, Núm. 8, pp. 1025-1033
-
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy
Journal of Infectious Diseases, Vol. 203, Núm. 11, pp. 1629-1636
-
Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline
AIDS, Vol. 25, Núm. 2, pp. 269-271
2010
-
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 24, Núm. 8
-
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV
Clinical Infectious Diseases, Vol. 51, Núm. 10, pp. 1209-1216